98 results on '"Canosa, A"'
Search Results
2. Sex-related Differences in ALS Survival and Progression: Insights from a Population-based Study (P6-11.004)
3. Association of Intermediate HTT CAG Repeats with Increased Risk and Disease Severity in Amyotrophic Lateral Sclerosis (P5-11.003)
4. Disentangling the Relationship Between Social Cognition, Executive Functions, and Behaviour Changes in Amyotrophic Lateral Sclerosis (S18.009)
5. Cognitive and Behavioral Features of Patients With Amyotrophic Lateral Sclerosis Who Are Carriers of the TARDBP Pathogenic Variant
6. Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort
7. Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without C9orf72 Mutation
8. ALS phenotype is influenced by age, sex, and genetics: A population-based study
9. Association of Copresence of Pathogenic Variants Related to Amyotrophic Lateral Sclerosis and Prognosis
10. The role of systemic immunity in ALS: a population-based study (P8-8.006)
11. Cognitive impairment across ALS clinical stages in a population-based cohort
12. The multistep hypothesis of ALS revisited: The role of genetic mutations
13. Unraveling the clinical and genetic spectrum of FUS-ALS (S11.006)
14. GBA Variants Influence Cognitive Status of ALS Patients (S11.004)
15. Brain Metabolic Changes in Amyotrophic Lateral Sclerosis with SOD1 Mutations (P1-1.Virtual)
16. Deciphering the Phenotype of ALS Patients with Intermediate ATXN2 PolyQ Expansion (S11.003)
17. The Use of Blood Carbonate (HCO3−) and Base-Excess (SBE) in Predicting Non-Invasive Ventilation (NIV) Adaptation (P1-1.Virtual)
18. Mutational Analysis of Known ALS Genes in an Italian Population-Based Cohort
19. ALS phenotype is influenced by age, sex, and genetics
20. A different cognitive and behavioral profile in ALS patients with or without C9orf72 expansion (4141)
21. Lateralization of Motor Damage Influences the Features of Cognitive Impairment in ALS. (2519)
22. Metabolic Brain Changes Across Different Levels Of Cognitive Impairment In ALS: A 18F-FDG-PET Study (4129)
23. Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without
24. Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without C9orf72 Mutation
25. A 18F-FDG-PET Study on Brain Metabolic Correlates of King’s Staging System in ALS (1835)
26. Brain Metabolic Correlates of Apathy in an ALS Cohort: A 18F-FDG PET Study (2191)
27. Role of hnRNPA1 in an Italian ALS Population-Based Cohort (2314)
28. Cognitive impairment across ALS clinical stages in a population-based cohort
29. Correlation of cognitive impairment and KING’s and MiTos staging in ALS: a crosssectional population-based study. (S54.007)
30. Lifetime Sport Practice and Brain Metabolism in Amyotrophic Lateral Sclerosis: a 18F-FDG-PET study (P1.4-028)
31. Advance directives of treatment in ALS patients: The Piedmont and Valle d’Aosta register experience in the 2008–2013 period. (P2.6-053)
32. Progression of Symptoms in relation to the Site of Onset in Amyotrophic Lateral Sclerosis: new Evidence supporting the Prion-like Hypothesis (P4.6-004)
33. Validation of the revised classification of cognitive and behavioral impairment in ALS (P1.4-008)
34. The multistep hypothesis of ALS revisited: The role of genetic mutations
35. Differential Neuropsychological Profile of Patients With Amyotrophic Lateral Sclerosis With and Without Mutation.
36. The natural history of dysphagia in ALS patients with bulbar and spinal onset (P4.432)
37. Are ALS Motor Phenotypes stochastic? (P5.167)
38. Secular trends of ALS incidence in an Italian population-based register, 1995–2014: evidence for a cohort effect in women (S15.005)
39. The polymorphisms of CX3CR1 gene influence ALS survival in an Italian population-based study (S3.008)
40. Extrapyramidal involvement in ALS: a prospective population-based study (P4.314)
41. C9ORF72 Is a Stronger Determinant Than APOE of Cognitive Impairment in ALS (S21.008)
42. Metabolic Spatial Connectivity in Amyotrophic Lateral Sclerosis: A 18F-FDG PET Study (P4.099)
43. ALS clinical trials: do enrolled patients accurately represent the ALS population?
44. 18F-FDG-PET correlates of cognitive impairment in ALS
45. Advance directives and palliative care in ALS patients. The Piedmont and Valle d’Aosta register experience (I8-5D)
46. Are arterial hypertension and diabetes modifiers of ALS phenotype and outcome? A population-based study (P6.101)
47. ATXN2 PolyQ Intermediate Repeat Modifies ALS Phenotype and Survival (I8-3B)
48. ATXN2 PolyQ Intermediate Repeat Modifies ALS Phenotype and Survival (P2.005)
49. Advance directives and palliative care in ALS patients. The Piedmont and Valle d’Aosta register experience (S10.007)
50. Cognitive Reserve in ALS with Comorbid Frontotemporal Dementia (FTD): A Population-Based Study (P5.081)
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.